Long-Term Outcome of Segmental Duct Injected Pancreas: Three to 13 Years Survival

Tajra, Luis Carlos Feitosa; Dubernard, Jean Michel; Dawhara, M; Benchaid, M.; Ishibashi, M; Lefrançois, N; Martín, Xavier

doi:10.1016/s0041-1345(97)01278-5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Surgical Aspects1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1999

2004

Publication Types

Select...

Article1

Book1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another technique involves obliterating the pancreatic duct by intraductal administration of synthetic polymers[24]. Some centres in Europe now have up to 10 years experience of duct occlusion techniques[25] and, although it is still more popular in France, it has up to a 70% local complication rate (e.g. collections or fistulas)[26].…”

Section: Surgical Aspectsmentioning

confidence: 99%

Vascularized pancreas allotransplantation – clinical indications and outcome

1999

View full text Add to dashboard Cite

VPT is an attractive option to offer Type 1 DM patients who need or already have a renal allograft. Patients have to decide between the increased surgical risk and the risks of long-term immunosuppression and the benefits of improved QoL. In the absense of end-stage renal failure (ESRF) there is no justification for PTA, except where the diabetes itself poses a greater risk to life than the transplantation procedure.

show abstract

Section: Surgical Aspectsmentioning

confidence: 99%